918 related articles for article (PubMed ID: 22983084)
21. Intra-pleural fibrinolytic therapy vs. conservative management in the treatment of parapneumonic effusions and empyema.
Cameron R
Cochrane Database Syst Rev; 2000; (3):CD002312. PubMed ID: 10908554
[TBL] [Abstract][Full Text] [Related]
22. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study.
Bouros D; Schiza S; Patsourakis G; Chalkiadakis G; Panagou P; Siafakas NM
Am J Respir Crit Care Med; 1997 Jan; 155(1):291-5. PubMed ID: 9001327
[TBL] [Abstract][Full Text] [Related]
23. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema.
Cameron R; Davies HR
Cochrane Database Syst Rev; 2008 Apr; (2):CD002312. PubMed ID: 18425881
[TBL] [Abstract][Full Text] [Related]
24. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.
Khemasuwan D; Sorensen J; Griffin DC
Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674
[TBL] [Abstract][Full Text] [Related]
25. Parapneumonic effusions and empyema.
Light RW
Proc Am Thorac Soc; 2006; 3(1):75-80. PubMed ID: 16493154
[TBL] [Abstract][Full Text] [Related]
26. Minimally invasive treatment of complicated parapneumonic effusions and empyemas in adults.
Porcel JM
Clin Respir J; 2018 Apr; 12(4):1361-1366. PubMed ID: 29087029
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of intrapleural instillation of alteplase in the management of complicated pleural effusion or empyema.
Thommi G; Nair CK; Aronow WS; Shehan C; Meyers P; McLeay M
Am J Ther; 2007; 14(4):341-5. PubMed ID: 17667208
[TBL] [Abstract][Full Text] [Related]
28. Intrapleural tissue plasminogen activator for the treatment of parapneumonic effusion.
Hamblin SE; Furmanek DL
Pharmacotherapy; 2010 Aug; 30(8):855-62. PubMed ID: 20653362
[TBL] [Abstract][Full Text] [Related]
29. A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions.
Thommi G; Shehan JC; Robison KL; Christensen M; Backemeyer LA; McLeay MT
Respir Med; 2012 May; 106(5):716-23. PubMed ID: 22398159
[TBL] [Abstract][Full Text] [Related]
30. Fibrinolysis treatment for loculated parapneumonic pleural effusion secondary to right lower lobe pneumonia.
Merlo LG; Ansari S; Singh B; Teferedgin FF; Cervellione KL; Gintautas J; Babury MA
Proc West Pharmacol Soc; 2009; 52():11-3. PubMed ID: 22128410
[TBL] [Abstract][Full Text] [Related]
31. Intrapleural fibrinolysis for parapneumonic effusion and empyema in children.
Wells RG; Havens PL
Radiology; 2003 Aug; 228(2):370-8. PubMed ID: 12893898
[TBL] [Abstract][Full Text] [Related]
32. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema.
Cameron R; Davies HR
Cochrane Database Syst Rev; 2004; (2):CD002312. PubMed ID: 15106174
[TBL] [Abstract][Full Text] [Related]
33. The approach to the patient with a parapneumonic effusion.
Wrightson JM; Davies RJ
Semin Respir Crit Care Med; 2010 Dec; 31(6):706-15. PubMed ID: 21213202
[TBL] [Abstract][Full Text] [Related]
34. Utility of fibrinolytic agents for draining intrapleural infections.
Bouros D; Schiza S; Siafakas N
Semin Respir Infect; 1999 Mar; 14(1):39-47. PubMed ID: 10197396
[TBL] [Abstract][Full Text] [Related]
35. Complicated parapneumonic effusion and empyema thoracis: microbiology and predictors of adverse outcomes.
Tsang KY; Leung WS; Chan VL; Lin AW; Chu CM
Hong Kong Med J; 2007 Jun; 13(3):178-86. PubMed ID: 17548905
[TBL] [Abstract][Full Text] [Related]
36. [Management of parapneumonic pleural effusions].
Asensio de la Cruz O; Blanco González J; Moreno Galdó A; Pérez Frías J; Salcedo Posadas A; Sanz Borrell L;
An Esp Pediatr; 2001 Mar; 54(3):272-82. PubMed ID: 11262257
[TBL] [Abstract][Full Text] [Related]
37. Use of fibrinolytic agents in the management of complicated parapneumonic effusions and empyemas.
Sahn SA
Thorax; 1998 Aug; 53 Suppl 2(Suppl 2):S65-72. PubMed ID: 10193351
[TBL] [Abstract][Full Text] [Related]
38. [Drug treatment with fibrinolytics (corrected) of secondary empyema secondary to complicated parapneumonic effusion].
Diéguez EV; Alapont VM; San Román CG; Micó SV; Viguer CG
Cir Pediatr; 2009 Jul; 22(3):162-7. PubMed ID: 19957867
[TBL] [Abstract][Full Text] [Related]
39. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions.
Chin NK; Lim TK
Chest; 1997 Feb; 111(2):275-9. PubMed ID: 9041968
[TBL] [Abstract][Full Text] [Related]
40. Intrapleural streptokinase for empyema and complicated parapneumonic effusions.
Diacon AH; Theron J; Schuurmans MM; Van de Wal BW; Bolliger CT
Am J Respir Crit Care Med; 2004 Jul; 170(1):49-53. PubMed ID: 15044206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
